Setting the Bar High
In earnings season, one of the key metrics traders await is whether a company missed, met, or beat analysts' views. Of course, the actual earnings number often turns out to be less important than the outlook, in terms of how the stock is traded after the report. Even so, one of my screens is set for stocks of companies expected to see earnings growth of 25% in the coming report, and in the next fiscal year.
That's a high bar, but there are companies out there with such forecasts. Among the higher-profile growth names reporting soon are Alexion Pharmaceuticals (ALXN) and Questcor Pharmaceutical (QCOR). Both are set to report April 24 -- Alexion before the open, and Questcor after the close. Alexion is seen earning $0.39 a share, up 30% from a year earlier. Questcor is expected to bring in $0.52 per share in the quarter, which would be a gain of 160% from the year-earlier quarter....355 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.